The Role of Mesothelial Omentin in Ovarian Cancer Progression
Abstract
We hypothesize that omentin (ITLN1) suppresses ovarian cancer progression by sequestering lactotransferrin (LTF) from its receptor (LRP1) on the ovarian cancer cells and adipocytes, and that lactotransferrin promotes ovarian cancer cells motility and growth. The most significant finding in this research period are (1) exogenous omentin suppresses ovarian cancer cells motility and invasive potential, (2) matrix etalloproteinase-1 (MMP1) mediated the effects of omentin on suppressing ovarian cancer cells motility and invasive potential, (3) ITLN1 abrogates LTFs effects on ovarian cancer cells motility and invasive potential (4) omentin suppressed ovarian cancer growth by enhancing insulin-dependent glucose in adipocytes via facilitative glucose transporter (GLUT4/SLC2A4), and (5) exogenous omentin suppressed ovarian cancer progression in vivo.
Document Details
- Document Type
- Technical Report
- Publication Date
- May 01, 2020
- Accession Number
- AD1111981
Entities
People
- Kay-Pong Yip
Organizations
- University of South Florida